In this episode of Parallax, host Dr Ankur Kalra is joined by Dr Adam DeVore (Duke University School of Medicine, US) to discuss the management of patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) and the persistent risk of sudden cardiac death during the early phase after diagnosis.
The discussion explores strategies for initiating and optimising guideline-directed medical therapy, approaches to risk stratification using imaging and clinical assessment, and the evolving role of wearable cardioverter defibrillators while patients await recovery or evaluation for ICD therapy. The faculty also review key findings from the SCD-PROTECT study and their implications for real-world clinical practice.
This series is supported by ZOLL and is intended for Health Care Professionals.
Podden och tillhörande omslagsbild på den här sidan tillhör
Radcliffe Cardiology. Innehållet i podden är skapat av Radcliffe Cardiology och inte av,
eller tillsammans med, Poddtoppen.